Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALEXANDRIA REAL ESTATE EQUITIES, INC.ARE · Entity 419 | Director | January 15, 2026 | January 20, 2026 |
| BIOGEN INC.BIIB · Entity 1675 | Director | June 09, 2026 | June 11, 2026 |
| EXELIXIS, INC.EXEL · Entity 3386 | Director | May 27, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Report date January 15, 2026 · Filed January 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,946 |
Reported balance
After 2026-01-15 transaction · row 1
1 source rowRow 1 · 2026-01-15 · Grant · Acquired 3,493 · Balance 10,946 |
BIOGEN INC.
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,820 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 2,005 · Balance 8,820 F1: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.
EXELIXIS, INC.
Report date May 27, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 109,186 |
Reported balance
After 2026-05-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 8,367 · Balance 109,186 F1: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. F2: Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date.
F2: Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 11, 2026 21:09 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantCommon Stock | 2,005 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000052 · form4.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,820 F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026. Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:43 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 8,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-26-000079 · wk-form4_1780091007.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,186 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| May 07, 2026 Filed May 8, 2026 23:03 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 20,634 | $0.00 Strike: $19.77 | $0.00 |
DisclosureSEC source: 0000939767-26-000062 · wk-form4_1778281421.xml · derivative · entry 3 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,634 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 20,634 shares of Common Stock, became fully exercisable on May 23, 2019. Read SEC document |
| May 07, 2026 Filed May 8, 2026 23:03 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 20,634 | $46.00 | $949,164.00 |
DisclosureSEC source: 0000939767-26-000062 · wk-form4_1778281421.xml · nonDerivative · entry 2 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,819 F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| May 07, 2026 Filed May 8, 2026 23:03 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 20,634 | $19.77 | $407,934.18 |
DisclosureSEC source: 0000939767-26-000062 · wk-form4_1778281421.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 22:57 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | GrantCommon Stock | 3,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001547999-26-000002 · wk-form4_1768949843.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,946 Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 20:45 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantCommon Stock | 2,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-017761 · form4.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,815 Read SEC document |
| May 29, 2025 Filed May 30, 2025 23:13 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 9,812 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-25-000089 · wk-form4_1748646788.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,819 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 29, 2026, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 28,650 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 01:31 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 28,240 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0000939767-25-000022 · wk-form4_1740015080.xml · derivative · entry 5 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,240 shares Expires 2025-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 28,240 shares of Common Stock, became fully exercisable on April 5, 2018. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 01:31 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,874 | $0.00 Strike: $20.50 | $0.00 |
DisclosureSEC source: 0000939767-25-000022 · wk-form4_1740015080.xml · derivative · entry 4 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,874 shares Expires 2025-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,874 shares of Common Stock, became fully exercisable on May 24, 2018. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 01:31 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 44,114 | $34.94 | $1,541,343.16 |
DisclosureSEC source: 0000939767-25-000022 · wk-form4_1740015080.xml · nonDerivative · entry 3 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,007 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.92 to $35.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F1 · balance_after: Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 01:31 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 28,240 | $22.10 | $624,104.00 |
DisclosureSEC source: 0000939767-25-000022 · wk-form4_1740015080.xml · nonDerivative · entry 2 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 01:31 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,874 | $20.50 | $325,417.00 |
DisclosureSEC source: 0000939767-25-000022 · wk-form4_1740015080.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:42 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | GrantCommon Stock | 2,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001035443-25-000048 · wk-form4_1737150150.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,453 Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 23:35 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 8,250 | $26.56 | $219,120.00 |
DisclosureSEC source: 0000939767-24-000130 · wk-form4_1723851308.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,007 F1 · balance_after: Includes 18,838 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock. Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 21:13 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantCommon Stock | 1,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-019234 · form4.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,445 Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 00:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 18,838 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-24-000100 · wk-form4_1717546840.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,257 F1 · date: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 100% of the shares subject to the RSU award on May 31, 2025, subject to the Reporting Person's continuous service through that date. F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 100% of the shares subject to the RSU award on May 31, 2025, subject to the Reporting Person's continuous service through that date. F2 · balance_after: Includes 39,556 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of RSUs. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 21:44 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | GrantCommon Stock | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001035443-24-000060 · wk-form4_1705527839.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,421 Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 23:00 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantCommon Stock | 960 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019542 · form4.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,105 Read SEC document |
| June 01, 2023 Filed Jun 3, 2023 01:22 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 20,718 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-23-000060 · wk-form4_1685755327.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,419 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on June 1, 2024, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 20,718 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 21:44 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001035443-23-000080 · wf-form4_167407824114178.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,836 Read SEC document |
| July 29, 2022 Filed Aug 1, 2022 21:09 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | SaleCommon Stock | 289 | $164.59 | $47,566.51 |
DisclosureSEC source: 0001035443-22-000234 · wf-form4_165938815485074.xml · nonDerivative · entry 2 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,711 Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 21:09 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | SaleCommon Stock | 2,311 | $163.04 | $376,785.44 |
DisclosureSEC source: 0001035443-22-000234 · wf-form4_165938815485074.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:32 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantCommon Stock | 1,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017779 · form4.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,145 Read SEC document |
| May 26, 2022 Filed May 28, 2022 00:07 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 19,575 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000072 · wf-form4_165369644552534.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,701 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 26, 2023, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 19,575 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 21:55 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | GrantCommon Stock | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0001035443-22-000029 · wf-form4_164262928982114.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,311 Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 21:28 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-021337 · form4.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775 Read SEC document |
| May 27, 2021 Filed May 29, 2021 00:21 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 16,598 | $0.00 Strike: $22.48 | $0.00 |
DisclosureSEC source: 0000939767-21-000062 · wf-form4_162224769762279.xml · derivative · entry 2 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,598 Underlying: Common Stock · 16,598 shares Expires 2028-05-26 F4 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| May 27, 2021 Filed May 29, 2021 00:21 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 8,299 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000062 · wf-form4_162224769762279.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,126 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 27, 2022, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 11,829 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 11, 2021 Filed May 18, 2021 00:15 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 8,275 | $25.01 | $206,957.75 |
DisclosureSEC source: 0000939767-21-000054 · wf-form4_162129692660785.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,827 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.08. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 11,258 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 21:41 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | GrantCommon Stock | 921 | $0.00 | $0.00 |
DisclosureSEC source: 0001035443-21-000028 · wf-form4_161117887705787.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,573 Read SEC document |
| May 21, 2020 Filed May 23, 2020 01:07 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 15,456 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0000939767-20-000099 · wf-form4_159019604061868.xml · derivative · entry 2 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,456 Underlying: Common Stock · 15,456 shares Expires 2027-05-20 F4 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| May 21, 2020 Filed May 23, 2020 01:07 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 7,728 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000099 · wf-form4_159019604061868.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,102 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 21, 2021, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 25,105 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 21:23 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | SaleCommon Stock | 1,465 | $174.20 | $255,203.00 |
DisclosureSEC source: 0001035443-20-000062 · wf-form4_158214736022333.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,652 Read SEC document |
| January 15, 2020 Filed Jan 18, 2020 00:10 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | GrantCommon Stock | 863 | $0.00 | $0.00 |
DisclosureSEC source: 0001035443-20-000024 · wf-form4_157930623519624.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,117 Read SEC document |
| May 23, 2019 Filed May 25, 2019 00:24 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 20,634 | $0.00 Strike: $19.77 | $0.00 |
DisclosureSEC source: 0000939767-19-000126 · wf-form4_155874387896369.xml · derivative · entry 2 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,634 Underlying: Common Stock · 20,634 shares Expires 2026-05-22 F4 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| May 23, 2019 Filed May 25, 2019 00:24 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 10,317 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-19-000126 · wf-form4_155874387896369.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,374 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 23, 2020, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 20,907 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:50 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | GrantCommon Stock | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001035443-19-000015 · wf-form4_154776182986245.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,254 Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 21:16 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | SaleCommon Stock | 3,000 | $128.67 | $386,010.00 |
DisclosureSEC source: 0001035443-18-000179 · wf-form4_153479976473886.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,344 F1 · price: The shares were sold at prices ranging from $128.40 to $128.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:21 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 15,874 | $0.00 Strike: $20.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000104 · wf-form4_152720767419905.xml · derivative · entry 2 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,874 Underlying: Common Stock · 15,874 shares Expires 2025-05-23 F4 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:21 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 7,937 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-18-000104 · wf-form4_152720767419905.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,057 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the sharessubject to the restricted stock unit award on May 24, 2019, subject to the Reporting Person's continuous service through such date. F3 · balance_after: Includes 22,057 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 21:55 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 28,240 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0000939767-18-000049 · wf-form4_152331090999767.xml · derivative · entry 2 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,240 Underlying: Common Stock · 28,240 shares Expires 2025-04-04 F4 · derivative.exercise_date: The option was granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the Transaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date, subject to the Reporting Peron's continuous service through such date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 21:55 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 14,120 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-18-000049 · wf-form4_152331090999767.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,120 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on each of the first four anniversaries of the Transaction Date, subject to the Reporting Person's continuous service through such date. F3 · balance_after: Includes 14,120 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 12, 2018 Filed Jan 18, 2018 02:04 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | GrantCommon Stock | 880 | $0.00 | $0.00 |
DisclosureSEC source: 0001035443-18-000017 · wf-form4_151624108029025.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,344 Read SEC document |
| May 04, 2017 Filed May 8, 2017 20:20 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | SaleCommon Stock | 2,174 | $113.30 | $246,314.20 |
DisclosureSEC source: 0001035443-17-000089 · wf-form4_149427482004928.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,464 Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 22:41 UTC | ALEXANDRIA REAL ESTATE EQUITIES, INC. ARE · Entity 419 | GrantCommon Stock | 1,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001035443-17-000007 · wf-form4_148477929620891.xml · nonDerivative · entry 1 Freire Maria C · CIK 0001547999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,638 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.